2026 Q3 Portfolio Activity
In 2026 Q3, GENERAL ATLANTIC, L.P. maintained a portfolio of 13 distinct positions. The most significant new addition was KORSANA, now representing 1.76% of the total fund value. They heavily accumulated shares in RISKIFIED, increasing the position by 100.0%. The fund also reduced its exposure to PHARVARIS by 74.8%.
Position History
hover any row below to update
Loading…
Total Positions
13
Quarter
2026 Q3
Top Holding
DLO (20.4%)
Top 10 Concentration
98.1%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-13 of 13
GENERAL ATLANTIC, L.P. Full Holdings List — 2026 Q3
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
DLO
DLOCAL
|
Technology | 20.42% | 20.86% |
#1
1
Prev: #2
|
6.0 |
—
|
-9,842,559 | -21.1% |
P
S
|
36,814,136 | $506,562,511 | 2021 Q2 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
CHYM
CHIME
|
Technology | 20.33% | 14.98% |
#2
1
Prev: #3
|
6.0 |
—
|
-2,333,056 | -11.0% |
P
S
|
18,926,627 | $504,205,343 | 2025 Q2 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
LFTO
LIFTOFF MOBILE
|
Communication Services | 16.12% | 20.92% |
#3
2
Prev: #1
|
6.0 |
—
|
no change | no change |
P
S
|
25,315,646 | $399,987,207 | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
XP
XP, INC
|
Financial Services | 15.20% | 11.50% |
#4
1
Prev: #5
|
5.0 |
—
|
-2,607,180 | -12.7% |
P
S
|
17,958,953 | $377,048,218 | 2019 Q4 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
ALKT
ALKAMI
|
Technology | 10.69% | 12.08% |
#5
1
Prev: #4
|
5.5 |
—
|
no change | no change |
P
S
|
19,379,038 | $265,299,030 | 2021 Q2 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
SPTX
SEAPORT THERAPE...
|
Healthcare | 4.96% | 4.56% |
#6
1
Prev: #7
|
3.0 |
—
|
no change | no change |
P
S
|
6,101,582 | $123,068,909 | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
RSKD
RISKIFIED
|
Technology | 3.40% | 0.92% |
#7
4
Prev: #11
|
4.4 |
—
|
5,324,998 | 100.0% |
P
S
|
10,649,996 | $84,241,468 | 2021 Q3 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
NRIX
NURIX THERAPEUT...
|
Healthcare | 2.90% | 2.53% |
#8
Prev: #8
|
2.2 |
—
|
no change | no change |
P
S
|
3,032,185 | $71,893,106 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
PHVS
PHARVARIS
|
Healthcare | 2.11% | 7.79% |
#9
3
Prev: #6
|
0.8 |
—
|
-4,899,267 | -74.8% |
P
S
|
1,651,490 | $52,385,263 | 2021 Q1 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
PBLS
PARABILIS MEDIC...
|
Healthcare | 2.00% | 1.45% |
#10
Prev: #10
|
1.8 |
—
|
no change | no change |
P
S
|
1,538,461 | $49,676,906 | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
KRSA
KORSANA
|
Healthcare | 1.76% | — |
#11
Prev: #—
|
4.2 |
—
|
1,366,242 | — |
NEW
|
1,366,242 | $43,719,744 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
GROV
GROVE COLLABORA...
|
Consumer Defensive | 0.11% | 0.11% |
#12
Prev: #12
|
1.0 |
—
|
no change | no change |
P
S
|
2,474,859 | $2,623,351 | 2023 Q2 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
RVMD
REVOLUTION MEDI...
|
Healthcare | 0.00% | 2.31% |
Sold All 😨
(Was: #9) |
0.0 |
—
|
-357,791 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2026-09-30 | 2026-11-13 |
Showing 1-13 of 13 holdings